strategic-management

254 MERNOUSH BANTON
EXHIBIT 3 Merck’s Sales by Product Categories
acquisition. Note the two divisions: (1) Pharmaceutical Products, and (2) Vaccines and
Infectious Diseases. Exhibit 3 gives details on some of Merck’s products.
Distribution
Merck sells its human health pharmaceutical products to drug wholesalers, distributors,
retailers, hospitals, government agencies, and managed health-care providers such as
health maintenance organizations, pharmacy benefit managers, and other institutions. The
company’s professional representatives communicate the effectiveness, safety, and value
of the products to health-care professionals in private practices, group practices, and
managed care organizations through samples, pamphlets, brochures, coupons, and rebates.
($ in millions) 2008 2007 2006
Pharmaceutical:
Singulair $ 4,336.9 $ 4,266.3 $ 3,579.0
Cozaar/Hyzaar 3,557.7 3,350.1 3,163.1
Fosamax 1,552.7 3,049.0 3,134.4
Januvia 1,397.1 667.5 42.9
Cosopt/Trusopt 781.2 786.8 697.1
Zocor 660.1 876.5 2,802.7
Maxalt 529.2 467.3 406.4
Propecia 429.1 405.4 351.8
Arcoxia 377.3 329.1 265.4
Vasotec/Vaseretic 356.7 494.6 547.2
Janumet 351.1 86.4 —
Proscar 323.5 411.0 618.5
Emend 263.8 204.2 130.8
Other pharmaceutical 2,278.9 2,422.9 2,780.5
Vaccine and infectious disease
product sales included in the
Pharmaceutical segment 2,187.6 1,800.5 1,315.8
Pharmaceutical segment revenues $19,382.9 $19,617.6 $19,835.6
Vaccines and Infectious Diseases:
Gardasil $ 1,402.8 $ 1,480.6 $ 234.8
ProQuad/M-M-R II/Varivax 1,268.5 1,347.1 820.1
RotaTeq 664.5 524.7 163.4
Zostavax 312.4 236.0 38.6
Hepatitis vaccines 148.3 279.9 248.5
Other vaccines 354.6 409.9 354.0
Primaxin 760.4 763.5 704.8
Cancidas 596.4 536.9 529.8
Isentress 361.1 41.3 —
Crixivan/Stocrin 275.1 310.2 327.3
Invanz 265.0 190.2 139.2
Other infectious disease 15.5 1.7 —
Vaccine and infectious disease
product sales included in the
Pharmaceutical segment (2,187.6) (1,800.5) (1,315.8)
continued